Skip to content

Altimmune, Inc.

ALT· NasdaqCore metricsCIK 1326190

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -16.84%
Market cap
$312.32M
194.59M shares
Filings
1,025
$41.00K
FY 2025+105.0% FY25 yoy
-$31.61M
Q3 2026N/M FY25 yoy
-$35.71M
Q3 2026N/M FY25 yoy
-$83.02M
Q3 2026derivedN/M FY25 yoy
-$0.15
Q3 2026N/M FY25 yoy
$28.89M
Q3 2026+18.5% FY25 yoy
$312.32M
—
7617.5×
0.7×
-21.63%
—

FY2025 figures · derived

Price

$1.6162.50%$2.68past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$41.00KFY 2025
$24.27M-$68.00K0FY 2010FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$41,000reported
FY 20242024-12-31$20,000reported
FY 20232023-12-31$426,000reported
FY 20222022-12-31$68,000reported
FY 20212021-12-31$4,410,356reported
FY 20202020-12-31$8,185,027reported
FY 20192019-12-31$5,801,401reported
FY 20182018-12-31$10,331,168reported
FY 20172017-12-31$10,738,322reported
FY 20162016-12-31$3,236,175reported
FY 20112011-12-31$24,266,274reported
FY 20102010-12-31$20,993,605reported

Pharmaceutical preparations

Altimmune, Inc. is the 249th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Altimmune, Inc. · CIK 1326190 · Engraved from SEC EDGAR